$18 Billion Needed to Defeat HIV, Malaria, and Tuberculosis

In Travel Vaccine News by Travel Vaccine

The Global Fund’s 2022 Results Report released today indicates a significant rebound for programs working to defeat HIV, tuberculosis (TB), and malaria.
In 2020, the COVID-19 pandemic had a devastating impact on the fight against these three diseases.
When the pandemic hit countries where the Global Fund works, the partnership rapidly mounted a response to deliver additional resources. 
Since March 2020, the Global Fund has invested more than US $4.4 billion to fight the pandemic and mitigate its impact on HIV, TB, and malaria.

Read More